Abstract
Bronchial asthma (BA) at high altitude (HA) has been studied for decades, but studies were limited to relatively low altitudes (below 3000 meters above sea level (MASL). Very scarce scientific evidence is available whether BA subjects can proceed to HA for recreational purposes and for work, and if they can, how well they will do. This paper summarizes past and current experience of BA patients stay at HA in Kyrgyzstan, mainly on a course of high-altitude climate therapy, and also reviews existing data from other countries, where BA patients travel to HA for various reasons. The existing conservative approach in assessing patients should be reassessed, and BA patients with well-controlled disease may be well at high altitude in light of evidence of beneficial effects of pollen concentration reduction, endogenous cortisol stimulation and reduced markers of inflammation.
Keywords: Asthma control, asthma, high altitude, hypoxia, screening, fitness for work.
Current Respiratory Medicine Reviews
Title:Asthma and High Altitude: Is It Safe to Be and Work?
Volume: 11 Issue: 3
Author(s): Nurlan Brimkulov and Denis Vinnikov
Affiliation:
Keywords: Asthma control, asthma, high altitude, hypoxia, screening, fitness for work.
Abstract: Bronchial asthma (BA) at high altitude (HA) has been studied for decades, but studies were limited to relatively low altitudes (below 3000 meters above sea level (MASL). Very scarce scientific evidence is available whether BA subjects can proceed to HA for recreational purposes and for work, and if they can, how well they will do. This paper summarizes past and current experience of BA patients stay at HA in Kyrgyzstan, mainly on a course of high-altitude climate therapy, and also reviews existing data from other countries, where BA patients travel to HA for various reasons. The existing conservative approach in assessing patients should be reassessed, and BA patients with well-controlled disease may be well at high altitude in light of evidence of beneficial effects of pollen concentration reduction, endogenous cortisol stimulation and reduced markers of inflammation.
Export Options
About this article
Cite this article as:
Brimkulov Nurlan and Vinnikov Denis, Asthma and High Altitude: Is It Safe to Be and Work?, Current Respiratory Medicine Reviews 2015; 11 (3) . https://dx.doi.org/10.2174/1573398X11666150905002813
DOI https://dx.doi.org/10.2174/1573398X11666150905002813 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacological Targeting of IDO-Mediated Tolerance for Treating Autoimmune Disease
Current Drug Metabolism The Role of Amitriptyline in the Management of Non-small Cell Lung Cancer
Current Cancer Therapy Reviews Bioactivities of Iridoids
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Optimization of Time Controlled 6-mercaptopurine Delivery for Site- Specific Targeting to Colon Diseases
Current Drug Delivery Biomarker-Detection Technologies for Comprehensive Medical Diagnosis During Deep-Space Missions
Recent Patents on Space Technology Diagnosis, Prevention and Treatment of Aspirin-Induced Asthma and Rhinitis
Current Drug Targets - Inflammation & Allergy Treating Neonatal Brain Injury - Promise and Inherent Research Challenges
Recent Patents on Inflammation & Allergy Drug Discovery Review and Research on Feature Selection Methods from NMR Data in Biological Fluids. Presentation of an Original Ensemble Method Applied to Atherosclerosis Field
Current Drug Metabolism Role of Plasmacytoid Dendritic Cells in Lung-Associated Inflammation
Recent Patents on Inflammation & Allergy Drug Discovery Biomarkers of Inflammation and Remodelling in Cystic Fibrosis
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Phytochemical-Mediated Glioma Targeted Treatment: Drug Resistance and Novel Delivery Systems
Current Medicinal Chemistry Type 2 Innate Lymphoid Cells in Allergic Disease
Current Immunology Reviews (Discontinued) Helminth Products as a Potential Therapeutic Strategy for Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Adenovirus and Post-Infectious Bronchiolitis Obliterans in Children
Current Pediatric Reviews Eicosanoids in Asthma, Allergic Inflammation, and Host Defense
Current Molecular Medicine Inotropic and Vasoactive Drugs in Pediatric ICU
Current Drug Targets Inflamm-Aging, Cytokines and Aging: State of the Art, New Hypotheses on the Role of Mitochondria and New Perspectives from Systems Biology
Current Pharmaceutical Design Antimicrobial Peptides in Burns and Wounds
Current Protein & Peptide Science Receptor-Based Design of Cytokine Therapeutics
Current Pharmaceutical Biotechnology Novel Approaches to Anti-Inflammatory Agents as Therapeutics for Asthma
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents